Complete Filing Data
Titan Acquisition Corp. reported Stockholders Equity of -$12.99 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Titan Acquisition Corp. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Net Income * | $7.2M | -$253.2K |
| Operating Income Loss | -$1.0M | -$253.2K |
| General And Administrative Expenses | $1.0M | $253.2K |
| General And Administrative Expense |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Net Income * | $2.8M | $2.6M | -$78.3K | -$44.9K | -$45.0K | -$78.2K |
| Operating Income Loss | -$153.1K | $53.4K | -$44.9K | -$45.0K | ||
| General And Administrative Expenses | $153.1K | -$53.4K | $44.9K | $45.0K | ||
| General And Administrative Expense | $78.3K | $78.2K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Stockholders Equity | -$13.0M | -$228.2K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $720.3K | $25.0K |
| Retained Earnings Accumulated Deficit | -$13.0M | -$253.2K |
| Liabilities And Stockholders Equity | $286.5M | $345.3K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $695.3K | $25.0K |
| Assets Current | $829.2K | $25.0K |
| Assets | $286.5M | $345.3K |
| Liabilities Current | $698.2K | $573.6K |
| Accounts Payable And Accrued Liabilities Current | $608.2K | $44.0K |
| Liabilities | $13.8M | $573.6K |
| Cash And Cash Equivalents At Carrying Value | ||
| Unrealized Gain Loss On Investments | $8.2M | |
| Other Accrued Liabilities Current | $320.3K | |
| Deferred Offering Costs | $320.3K | |
| Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests | $285.6M | |
| Deferred Underwriting Commission | $13.1M | |
| Cash Deposited In Trust Account | -$277.4M | |
| Assets Held In Trust | $285.6M | |
| Cash |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$12.2M | -$12.0M | -$306.5K | -$143.2K | -$98.3K | -$53.2K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $859.6K | $951.4K | $25.0K | $25.0K | $24.9K | $25.0K | |
| Retained Earnings Accumulated Deficit | -$12.2M | -$12.0M | -$331.5K | ||||
| Liabilities And Stockholders Equity | $283.9M | $281.1M | $509.2K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$17.00 | $25.0K | |||||
| Assets Current | $968.5K | $1.1M | $25.0K | ||||
| Assets | $283.9M | $281.1M | $509.2K | ||||
| Liabilities Current | $30.9K | $815.8K | |||||
| Accounts Payable And Accrued Liabilities Current | $30.9K | $107.3K | |||||
| Liabilities | $13.2M | $13.1M | |||||
| Cash And Cash Equivalents At Carrying Value | $859.6K | $951.4K | $25.0K | $25.0K | |||
| Unrealized Gain Loss On Investments | $2.9M | $2.6M | |||||
| Other Accrued Liabilities Current | $300.0K | ||||||
| Deferred Offering Costs | $484.3K | ||||||
| Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests | $282.9M | $280.0M | |||||
| Deferred Underwriting Commission | $13.1M | $13.1M | |||||
| Cash Deposited In Trust Account | |||||||
| Assets Held In Trust | $282.9M | $280.0M | |||||
| Cash | $859.6K | $951.4K | $25.0K | $25.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Increase Decrease In Accounts Payable And Accrued Liabilities | $564.2K | $44.0K |
| Net Cash Provided By Used In Financing Activities | $278.8M | $25.0K |
| Net Cash Provided By Used In Operating Activities | -$675.8K | |
| Proceeds From Issuance Of Common Stock | $25.0K | |
| Proceeds From Issuance Of Private Placement | $8.1M | |
| Proceeds From Issuance Initial Public Offering | $276.0M | |
| Net Cash Provided By Used In Investing Activities | -$277.4M | |
| Increase Decrease In Prepaid Insurance Current | $83.9K | |
| Increase Decrease In Prepaid Insurance | $21.0K | |
| Increase Decrease In Due To Related Party | $45.0K | -$135.0K |
| Increase Decrease In Deferred Charges | ||
| Increase Decrease In Other Accounts Payable |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 |
|---|---|---|
| Increase Decrease In Accounts Payable And Accrued Liabilities | $98.1K | $78.2K |
| Net Cash Provided By Used In Financing Activities | $25.0K | |
| Net Cash Provided By Used In Operating Activities | -$17.00 | -$17.00 |
| Proceeds From Issuance Of Common Stock | $25.0K | |
| Proceeds From Issuance Of Private Placement | ||
| Proceeds From Issuance Initial Public Offering | ||
| Net Cash Provided By Used In Investing Activities | ||
| Increase Decrease In Prepaid Insurance Current | ||
| Increase Decrease In Prepaid Insurance | ||
| Increase Decrease In Due To Related Party | ||
| Increase Decrease In Deferred Charges | $183.6K | |
| Increase Decrease In Other Accounts Payable | $163.8K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Preferred Stock Shares Outstanding | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 1.0M | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Due To Related Party | $90.0K | $135.0K |
| Other Income | $22.6K | |
| Due To Sponsor | $74.2K | |
| Additional Paid In Capital | $24.3K | |
| Issuance Of Class B Ordinary Shares To Sponsor | 25.0K | |
| Accretion For Class Ordinary Shares Subject To Redemption Amount | -31.7M | |
| Prepaid Insurance | $83.9K | |
| Payment Of Offering Costs | $5.4M | |
| Notes Assumed1 | ||
| Fair Value Of Public Warrants | $3.8M | |
| Due From Sponsor | $25.0K | |
| Allocated Value Of Transaction Costs To Public And Private Warrants | -$259.8K | |
| Prepaid Insurance Non Current | ||
| Issuance Of Private Units | $8.1M | |
| Increase In Due From Sposnor | $99.2K | -$74.2K |
| Unrealised Return | $8.2M | |
| Prepaid Expense Noncurrent | $21.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|
| Due To Related Party | $0.00 | $0.00 | $169.8K | $135.0K | |
| Other Income | $9.4K | $5.2K | |||
| Due To Sponsor | $238.6K | ||||
| Additional Paid In Capital | $24.3K | ||||
| Issuance Of Class B Ordinary Shares To Sponsor | 25.0K | ||||
| Accretion For Class Ordinary Shares Subject To Redemption Amount | -2.9M | -26.0M | |||
| Prepaid Insurance | $83.9K | $83.9K | |||
| Payment Of Offering Costs | |||||
| Notes Assumed1 | $300.0K | $161.6K | |||
| Fair Value Of Public Warrants | $3.8M | ||||
| Due From Sponsor | $25.0K | $25.0K | |||
| Allocated Value Of Transaction Costs To Public And Private Warrants | -$259.8K | ||||
| Prepaid Insurance Non Current | $42.0K | $62.9K | |||
| Issuance Of Private Units | $8.1M | ||||
| Increase In Due From Sposnor | |||||
| Unrealised Return | |||||
| Prepaid Expense Noncurrent |
Most recent annual filing with the SEC: March 31, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.